In this study, we used AAV-based gene transfer to correct NAGS deficiency in Nags−/− mice; we determined the dose of AAV vectors needed to prevent hyperammonemia after withdrawal of NCG + Cit supplementation from the treated Nags−/− mice, and measured expression of NAGS mRNA and protein in their livers. This evidence concerns the gene NAGS and Hyperammonemia.